122 related articles for article (PubMed ID: 29764839)
1. Lineage restriction analyses in CHIP indicate myeloid bias for
Buscarlet M; Provost S; Zada YF; Bourgoin V; Mollica L; Dubé MP; Busque L
Blood; 2018 Jul; 132(3):277-280. PubMed ID: 29764839
[TBL] [Abstract][Full Text] [Related]
2. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
[TBL] [Abstract][Full Text] [Related]
3. Natural history of clonal haematopoiesis seen in real-world haematology settings.
Patel SA; Gerber WK; Zheng R; Khanna S; Hutchinson L; Abel GA; Cerny J; DaSilva BA; Zhang TY; Ramanathan M; Khedr S; Selove W; Woda B; Miron PM; Higgins AW; Gerber JM
Br J Haematol; 2024 May; 204(5):1844-1855. PubMed ID: 38522849
[TBL] [Abstract][Full Text] [Related]
4. TET2 mutation as prototypic clonal hematopoiesis lesion.
Guarnera L; Jha BK
Semin Hematol; 2024 Feb; 61(1):51-60. PubMed ID: 38431463
[TBL] [Abstract][Full Text] [Related]
5. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
Huang YC; Wang CY
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
Borsi E; Vigliotta I; Poletti A; Mazzocchetti G; Solli V; Zazzeroni L; Martello M; Armuzzi S; Taurisano B; Kanapari A; Pistis I; Zamagni E; Pantani L; Rocchi S; Mancuso K; Tacchetti P; Rizzello I; Rizzi S; Dan E; Sinigaglia B; Cavo M; Terragna C
Cells; 2024 Apr; 13(8):. PubMed ID: 38667272
[TBL] [Abstract][Full Text] [Related]
7. Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans.
Kaasinen E; Kuismin O; Rajamäki K; Ristolainen H; Aavikko M; Kondelin J; Saarinen S; Berta DG; Katainen R; Hirvonen EAM; Karhu A; Taira A; Tanskanen T; Alkodsi A; Taipale M; Morgunova E; Franssila K; Lehtonen R; Mäkinen M; Aittomäki K; Palotie A; Kurki MI; Pietiläinen O; Hilpert M; Saarentaus E; Niinimäki J; Junttila J; Kaikkonen K; Vahteristo P; Skoda RC; Seppänen MRJ; Eklund KK; Taipale J; Kilpivaara O; Aaltonen LA
Nat Commun; 2019 Mar; 10(1):1252. PubMed ID: 30890702
[TBL] [Abstract][Full Text] [Related]
8. Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation.
Nam AS; Dusaj N; Izzo F; Murali R; Myers RM; Mouhieddine TH; Sotelo J; Benbarche S; Waarts M; Gaiti F; Tahri S; Levine R; Abdel-Wahab O; Godley LA; Chaligne R; Ghobrial I; Landau DA
Nat Genet; 2022 Oct; 54(10):1514-1526. PubMed ID: 36138229
[TBL] [Abstract][Full Text] [Related]
9. Cell of origin epigenetic priming determines susceptibility to Tet2 mutation.
Schiroli G; Kartha V; Duarte FM; Kristiansen TA; Mayerhofer C; Shrestha R; Earl A; Hu Y; Tay T; Rhee C; Buenrostro JD; Scadden DT
Nat Commun; 2024 May; 15(1):4325. PubMed ID: 38773071
[TBL] [Abstract][Full Text] [Related]
10. Molecular features of early onset adult myelodysplastic syndrome.
Hirsch CM; Przychodzen BP; Radivoyevitch T; Patel B; Thota S; Clemente MJ; Nagata Y; LaFramboise T; Carraway HE; Nazha A; Sekeres MA; Makishima H; Maciejewski JP
Haematologica; 2017 Jun; 102(6):1028-1034. PubMed ID: 28255022
[TBL] [Abstract][Full Text] [Related]
11. DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages.
Cobo I; Tanaka TN; Chandra Mangalhara K; Lana A; Yeang C; Han C; Schlachetzki J; Challcombe J; Fixsen BR; Sakai M; Li RZ; Fields H; Mokry M; Tsai RG; Bejar R; Prange K; de Winther M; Shadel GS; Glass CK
Immunity; 2022 Aug; 55(8):1386-1401.e10. PubMed ID: 35931086
[TBL] [Abstract][Full Text] [Related]
12. Clonal Hematopoiesis of Indeterminate Potential is Associated with Acute Kidney Injury.
Vlasschaert C; Robinson-Cohen C; Kestenbaum B; Silver SA; Chen JC; Akwo E; Bhatraju PK; Zhang MZ; Cao S; Jiang M; Wang Y; Niu A; Siew E; Kramer HJ; Kottgen A; Franceschini N; Psaty BM; Tracy RP; Alonso A; Arking DE; Coresh J; Ballantyne CM; Boerwinkle E; Grams M; Lanktree MB; Rauh MJ; Harris RC; Bick AG
medRxiv; 2023 May; ():. PubMed ID: 37292692
[TBL] [Abstract][Full Text] [Related]
13. Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?
Fulvio G; Baldini C; Mosca M; di Paolo A; Bocci G; Palumbo GA; Cacciola E; Migliorini P; Cacciola R; Galimberti S
Front Med (Lausanne); 2023; 10():1254868. PubMed ID: 37915324
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation disruption reshapes the hematopoietic differentiation landscape.
Izzo F; Lee SC; Poran A; Chaligne R; Gaiti F; Gross B; Murali RR; Deochand SD; Ang C; Jones PW; Nam AS; Kim KT; Kothen-Hill S; Schulman RC; Ki M; Lhoumaud P; Skok JA; Viny AD; Levine RL; Kenigsberg E; Abdel-Wahab O; Landau DA
Nat Genet; 2020 Apr; 52(4):378-387. PubMed ID: 32203468
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients.
Zhang CRC; Nix D; Gregory M; Ciorba MA; Ostrander EL; Newberry RD; Spencer DH; Challen GA
Exp Hematol; 2019 Dec; 80():36-41.e3. PubMed ID: 31812712
[TBL] [Abstract][Full Text] [Related]
16. Solid Organ Transplant Recipients Exhibit More TET2-Mutant Clonal Hematopoiesis of Indeterminate Potential Not Driven by Increased Transplantation Risk.
Silver AJ; Vlasschaert C; Mack T; Sharber B; Xu Y; Bick AG; Pinson CW; Savona MR
Clin Cancer Res; 2024 Jun; 30(11):2475-2485. PubMed ID: 38551504
[TBL] [Abstract][Full Text] [Related]
17. DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts.
Shumliakivska M; Luxán G; Hemmerling I; Scheller M; Li X; Müller-Tidow C; Schuhmacher B; Sun Z; Dendorfer A; Debes A; Glaser SF; Muhly-Reinholz M; Kirschbaum K; Hoffmann J; Nagel E; Puntmann VO; Cremer S; Leuschner F; Abplanalp WT; John D; Zeiher AM; Dimmeler S
Nat Commun; 2024 Jan; 15(1):606. PubMed ID: 38242884
[TBL] [Abstract][Full Text] [Related]
18. [TFH lymphoma and associated clonal hematopoiesis].
Nann D; Fend F; Quintanilla-Martinez L
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
[TBL] [Abstract][Full Text] [Related]
19. Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.
Marchetti A; Pelusi S; Marella A; Malvestiti F; Ricchiuti A; Ronzoni L; Lionetti M; Moretti V; Bugianesi E; Miele L; Vespasiani-Gentilucci U; Dongiovanni P; Federico A; Soardo G; D'Ambrosio R; McCain MV; Reeves HL; La Mura V; Prati D; Bolli N; Valenti L;
Hepatology; 2024 Mar; ():. PubMed ID: 38470216
[TBL] [Abstract][Full Text] [Related]
20. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes.
Nead KT; Kim T; Joo L; McDowell T; Wong J; Chan IC; Brock E; Zhao J; Xu T; Tang C; Lee CL; Abe JI; Bolton KL; Liao Z; Scheet P; Lin SH
Blood Adv; 2024 Jun; ():. PubMed ID: 38830141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
